skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure–activity relationship and a pharmacophore model

Abstract

Botulinum neurotoxins (BoNTs) are the most poisonous biological substance known to humans. They cause flaccid paralysis by blocking the release of acetylcholine at the neuromuscular junction. Here, we report a number of small molecule non-peptide inhibitors of BoNT serotype E. In addition, the structure–activity relationship and a pharmacophore model are presented. Although non-peptidic in nature, these inhibitors mimic key features of the uncleavable substrate peptide Arg-Ile-Met-Glu (RIME) of the SNAP-25 protein. Among the compounds tested, most of the potent inhibitors bear a zinc-chelating moiety connected to a hydrophobic and aromatic moiety through a carboxyl or amide linker. All of them show low micromolar IC 50 values.

Authors:
ORCiD logo [1];  [1];  [1]
  1. Brookhaven National Lab. (BNL), Upton, NY (United States). Biology Department
Publication Date:
Research Org.:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER) (SC-23)
OSTI Identifier:
1336050
Report Number(s):
BNL-112325-2016-JA
Journal ID: ISSN 0968-0896
Grant/Contract Number:
SC0012704; AC02-98CH10886; DEAC02-98CH10886
Resource Type:
Journal Article: Accepted Manuscript
Journal Name:
Bioorganic and Medicinal Chemistry
Additional Journal Information:
Journal Volume: 24; Journal Issue: 18; Journal ID: ISSN 0968-0896
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; Botulinum neurotoxin; fluorene; inhibitor; structure-activity relationship; pharmacophore

Citation Formats

Kumar, Gyanendra, Agarwal, Rakhi, and Swaminathan, Subramanyam. Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure–activity relationship and a pharmacophore model. United States: N. p., 2016. Web. doi:10.1016/j.bmc.2016.06.036.
Kumar, Gyanendra, Agarwal, Rakhi, & Swaminathan, Subramanyam. Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure–activity relationship and a pharmacophore model. United States. doi:10.1016/j.bmc.2016.06.036.
Kumar, Gyanendra, Agarwal, Rakhi, and Swaminathan, Subramanyam. 2016. "Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure–activity relationship and a pharmacophore model". United States. doi:10.1016/j.bmc.2016.06.036. https://www.osti.gov/servlets/purl/1336050.
@article{osti_1336050,
title = {Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure–activity relationship and a pharmacophore model},
author = {Kumar, Gyanendra and Agarwal, Rakhi and Swaminathan, Subramanyam},
abstractNote = {Botulinum neurotoxins (BoNTs) are the most poisonous biological substance known to humans. They cause flaccid paralysis by blocking the release of acetylcholine at the neuromuscular junction. Here, we report a number of small molecule non-peptide inhibitors of BoNT serotype E. In addition, the structure–activity relationship and a pharmacophore model are presented. Although non-peptidic in nature, these inhibitors mimic key features of the uncleavable substrate peptide Arg-Ile-Met-Glu (RIME) of the SNAP-25 protein. Among the compounds tested, most of the potent inhibitors bear a zinc-chelating moiety connected to a hydrophobic and aromatic moiety through a carboxyl or amide linker. All of them show low micromolar IC50 values.},
doi = {10.1016/j.bmc.2016.06.036},
journal = {Bioorganic and Medicinal Chemistry},
number = 18,
volume = 24,
place = {United States},
year = 2016,
month = 6
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 1work
Citation information provided by
Web of Science

Save / Share: